Dana-Farber Research on Phase 3 Trials for Breast, Rectal, Kidney, and Brain Cancer at ASCO Meeting miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
For high-risk patients with prostate cancer, treatment with novel hormonal agents (NHAs) followed by surgery can reduce the risk of recurrent and progressive cancer, compared to initial treatment with surgery, suggests a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA).
For high-risk patients with prostate cancer, treatment with novel hormonal agents (NHAs) followed by surgery can reduce the risk of recurrent and progressive ca
/PRNewswire/ The Prostate Cancer Foundation (PCF) today announced the Class of 2021 Young Investigator Award recipients totaling nearly $6.5 million in.